Wednesday, April 9, 2025
31.9 C
Bengaluru

A Social Experiment

MedicinMan May 2015

[wpfilebase tag=file id=47 tpl=download-button /]

Inside this Issue

1. Doctor Profiling for Sales Success by RB Balakrishna

A Doctor Profile enables the Medical Rep to tailor-make his detailing approach to each Doctor, ensuring sales success.

2.  Using Gamification to Achieve a State of Flow while Learning by Rajiv Jayaraman

By turning learning into a game, learners enter into a ‘state of flow’ – a condition where the ‘high’ of the game makes learning a habit.

3.  The 3 ‘E’s of Sales Leadership: Engage,  Empower &  Enable by K. Hariram

How to move from being mere sales ‘managers’ to being sales ‘leaders’.

4.  Focus Feature: Brand Life Cycle Management by Vivek Hattangadi

With few new chemical entities in the pipeline, pharma companies will have devote more attention to managing the life cycle of their brands to derive maximum mileage from existing products.

5.  Lost Patients by Hanno Wolfram

By ignoring the pharmacist, pharma companies are losing out on meeting the health needs of many patients.

Hot this week

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...

Topics

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...

FLUX – Indian Pharma in the Post VUCA World

Introduction For decades, leaders and organizations have relied on the...

Indian Pharma Market (IPM) Highlights – January 2025

Overall IPM Performance: Monthly Growth: IPM monthly growth reached 8.4% in...
spot_img

Related Articles

spot_imgspot_img
Previous article
Next article